IRIS
Del Re, Marzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 59
EU - Europa 33
NA - Nord America 4
Totale 96
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 53
IT - Italia 29
HK - Hong Kong 4
NL - Olanda 3
US - Stati Uniti d'America 3
GB - Regno Unito 1
IR - Iran 1
MX - Messico 1
TR - Turchia 1
Totale 96
Salva come PNG Salva come JPEG
Città #
Rome 25
Singapore 11
Hong Kong 4
Milan 2
Ashburn 1
Council Bluffs 1
Livorno 1
Mexico City 1
Santa Clara 1
Totale 47
Salva come PNG Salva come JPEG
Nome #
EGFR signaling pathway as therapeutic target in human cancers 6
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 4
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 4
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 4
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 4
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 3
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 3
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy 3
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 3
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data 3
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 3
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 3
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 3
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 3
Clinical, diagnostic and therapeutic framework of mHSPC and nmCRPC: a multidisciplinary consensus project of the Italian Society for Uro-Oncology (SIUrO) 3
Impact of IVS14+1G>A and 2846A>T DPYD polymorphisms on toxicity outcome of patients treated with fluoropyrimidine-containing regimens 3
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies 3
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients 3
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 3
ErbB in NSCLC as a molecular target: Current evidences and future directions 3
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 3
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials 3
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer 2
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 2
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 2
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation 2
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma 2
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA 2
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 2
Covalent Bruton tyrosine kinase inhibitors across generations: A focus on zanubrutinib 2
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer 2
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 2
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone 2
KRAS inhibition in non–small cell lung cancer: Past failures, new findings and upcoming challenges 2
Facing an un-met need in lung cancer screening: The never smokers 2
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 2
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives 2
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation 2
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 2
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 2
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies 2
Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients 2
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 2
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer 2
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 2
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 2
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies 2
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm 2
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 2
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 2
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 2
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 2
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World 2
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) 2
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 2
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 2
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 2
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 2
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight 2
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review 2
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project 2
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 2
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice 2
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 2
Understanding EGFR heterogeneity in lung cancer 2
Author's reply. The detection of AR-V7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients 2
Cross-Linked Hyaluronic Acid as Tear Film Substitute 2
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 2
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 2
Author's reply. Should CYP2D6 be genotyped when treating with tamoxifen? Pharmacogenomics 2
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer 2
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer 1
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 1
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 1
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer 1
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 1
Nicotine Metabolite Ratio in Smokers: A Real World Experience 1
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 1
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 1
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 1
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA 1
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 1
Detection of BRAF and KRAS mutations in DNA released by tumors in peripheral blood by an advanced digital droplet PCR 1
PLASMA/SALIVA AND GENOTYPIC/PHENOTYPIC DIFFERENCES OF NICOTINE METABOLITE RATIO 1
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics 1
Predicting Fluoropyrimidine-Related Toxicity: Turning Wish to Will, The Pamm-Eortc Position 1
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors 1
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation 1
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 1
Targeting HER2 in breast cancer with brain metastases: A pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments 1
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment 1
Empower the potential of trastuzumab deruxtecan with novel combinations 1
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 1
Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response 1
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients 1
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 1
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma 1
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 1
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence 1
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies 1
Totale 200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025214 0 0 0 44 19 50 69 32 0 0 0 0
Totale 214